CD79A and Cirrhosis: The rate of ASCA IgA and/or IgG and also anti-OMP PlusTM IgA seropositivity was greatly elevated in patients with liver cirrhosis compared to healthy controls (ORASCAeither: 3.28, 95% CI: 1.83–5.89; ORanti-OMP PlusTM: 6.69, 95% CI: 3.88–11.55) or chronic liver diseases without cirrhosis (p<0.001 for both).